BlackRock Portfolio holdings
AUM
$5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
-14.18%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$3.11T
AUM Growth
-$591B
(-16%)
Cap. Flow
+$11B
Cap. Flow
% of AUM
0.36%
Top 10 Holdings %
Top 10 Hldgs %
18.96%
Holding
6,012
New
226
Increased
2,722
Reduced
2,341
Closed
173
Top Buys
| 1 |
Warner Bros
WBD
|
+$2.23B |
| 2 |
Linde
LIN
|
+$2.16B |
| 3 |
Pfizer
PFE
|
+$1.42B |
| 4 |
UnitedHealth
UNH
|
+$1.38B |
| 5 |
Chevron
CVX
|
+$1.34B |
Top Sells
| 1 |
AT&T
T
|
+$3.94B |
| 2 |
CERN
Cerner Corp
CERN
|
+$2.23B |
| 3 |
Baidu
BIDU
|
+$1.2B |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.1B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$850M |
Sector Composition
| 1 | Technology | 22.34% |
| 2 | Healthcare | 15.26% |
| 3 | Financials | 12.36% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3676
Schwab US Broad Market ETF
SCHB
$36.8B
| $3.93M | ﹤0.01% |
266,808
-8,823
| -3% | -$130K |
|
3677
Atossa Therapeutics
ATOS
$108M
| $3.91M | ﹤0.01% |
3,588,683
-5,848,351
| -62% | -$6.38M |
|
|
RDBX
3678
DELISTED
Redbox Entertainment Inc. Class A Common Stock
RDBX
| $3.91M | ﹤0.01% |
528,583
+525,937
| +19,877% | +$3.89M |
|
3679
Daktronics
DAKT
$1.14B
| $3.91M | ﹤0.01% |
1,297,815
-1,672,718
| -56% | -$5.03M |
|
3680
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.01B
| $3.9M | ﹤0.01% |
123,638
-4,432
| -3% | -$140K |
|
3681
MoonLake Immunotherapeutics
MLTX
$3.34B
| $3.9M | ﹤0.01% |
741,906
| – | – |
|
3682
Taysha Gene Therapies
TSHA
$837M
| $3.89M | ﹤0.01% |
1,046,490
-1,147,213
| -52% | -$4.27M |
|
3683
Aldeyra Therapeutics
ALDX
$324M
| $3.89M | ﹤0.01% |
974,947
-2,245,564
| -70% | -$8.96M |
|
3684
ClearPoint Neuro
CLPT
$298M
| $3.88M | ﹤0.01% |
297,693
-872,160
| -75% | -$11.4M |
|
3685
Richardson Electronics
RELL
$141M
| $3.88M | ﹤0.01% |
264,391
-1,740
| -0.7% | -$25.5K |
|
3686
Local Bounti
LOCL
$48.7M
| $3.87M | ﹤0.01% |
93,614
+66,021
| +239% | +$2.73M |
|
3687
KT
KT
$9.52B
| $3.86M | ﹤0.01% |
276,357
-1,674,639
| -86% | -$23.4M |
|
3688
The Oncology Institute
TOI
$285M
| $3.84M | ﹤0.01% |
+758,095
| New | +$3.84M |
|
3689
iShares Russell Mid-Cap Value ETF
IWS
$14.2B
| $3.83M | ﹤0.01% |
37,745
+31,803
| +535% | +$3.23M |
|
3690
Vroom, Inc. Common Stock
VRM
$137M
| $3.83M | ﹤0.01% |
38,269
-39,830
| -51% | -$3.98M |
|
3691
Precision BioSciences
DTIL
$54.3M
| $3.81M | ﹤0.01% |
79,419
-72,804
| -48% | -$3.5M |
|
3692
Zevra Therapeutics
ZVRA
$435M
| $3.8M | ﹤0.01% |
852,849
-1,400,485
| -62% | -$6.25M |
|
|
THRX
3693
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $3.8M | ﹤0.01% |
687,359
+142,504
| +26% | +$788K |
|
|
PLM
3694
DELISTED
PolyMet Mining Corp.
PLM
| $3.8M | ﹤0.01% |
1,381,202
+36,213
| +3% | +$99.6K |
|
3695
BlackRock TCP Capital
TCPC
$605M
| $3.79M | ﹤0.01% |
302,179
-50,389
| -14% | -$631K |
|
|
DAO
3696
Youdao
DAO
$1.06B
| $3.77M | ﹤0.01% |
765,357
+57,653
| +8% | +$284K |
|
|
ARC
3697
DELISTED
ARC Document Solutions, Inc.
ARC
| $3.74M | ﹤0.01% |
1,423,341
-3,926
| -0.3% | -$10.3K |
|
3698
Limoneira
LMNR
$275M
| $3.73M | ﹤0.01% |
264,544
-762,899
| -74% | -$10.8M |
|
3699
ADC Therapeutics
ADCT
$372M
| $3.71M | ﹤0.01% |
466,804
+162,575
| +53% | +$1.29M |
|
|
AKUS
3700
DELISTED
Akouos, Inc. Common Stock
AKUS
| $3.67M | ﹤0.01% |
782,709
-1,194,485
| -60% | -$5.6M |
|